<DOC>
	<DOCNO>NCT00284154</DOCNO>
	<brief_summary>This clinical trial involve administration chemotherapeutic medication vinflunine . Vinflunine approve FDA experimental treatment extensive small cell lung cancer . The purpose research trial study effectiveness vinflunine patient relapse extensive small cell lung cancer , evaluate toxicity , evaluate long response drug last .</brief_summary>
	<brief_title>Vinflunine Treatment Patients With Relapsed Extensive Small Cell Lung Cancer</brief_title>
	<detailed_description>Eligible patient receive vinflunine 15-20 minute intravenous ( IV ) infusion every three week ( 21 day ) . This three week treatment period call cycle . Patients whose cancer grown decrease size may receive 6 cycle vinflunine . Evaluation conduct every cycle .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Small Cell</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Small cell lung cancer progression one previous chemotherapy chemotherapy/radiation therapy regimen Measurable evaluable disease Able perform activity daily live minimal assistance Adequate hematological , liver , kidney function Must give write informed consent prior entry CNS involvement Serious active infection underlie medical condition Significant history uncontrolled cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Extensive stage</keyword>
	<keyword>Relapsed</keyword>
</DOC>